{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T05:20:36Z","timestamp":1754112036545},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Key Science and Technology Fund of Henan Province","award":["182102110341","182102110120"],"award-info":[{"award-number":["182102110341","182102110120"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.ejphar.2018.12.006","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T17:53:35Z","timestamp":1544118815000},"page":"139-144","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Tenofovir disoproxil fumarate induces pheochromocytoma cells apoptosis"],"prefix":"10.1016","volume":"844","author":[{"given":"Mengmeng","family":"Lu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongjing","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dengke","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hongliang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2018.12.006_bib1","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/j.nicl.2017.11.025","article-title":"Alteration of brain network topology in HIV-associated neurocognitive disorder: a novel functional connectivity perspective","volume":"17","author":"Abidin","year":"2018","journal-title":"NeuroImage: Clin."},{"key":"10.1016\/j.ejphar.2018.12.006_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12325-010-0006-9","article-title":"Abacavir\/lamivudine fixed-dose combination antiretroviral therapy for the treatment of HIV","volume":"27","author":"Achenbach","year":"2010","journal-title":"Adv. Ther."},{"key":"10.1016\/j.ejphar.2018.12.006_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1743-8454-3-1","article-title":"The distribution of the anti-HIV drug, tenofovir (PMPA), into the brain, CSF and choroid plexuses","volume":"3","author":"Anthonypillai","year":"2006","journal-title":"Cereb. Fluid Res."},{"key":"10.1016\/j.ejphar.2018.12.006_bib4","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1212\/01.WNL.0000287431.88658.8b","article-title":"Updated research nosology for HIV-associated neurocognitive disorders","volume":"69","author":"Antinori","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.ejphar.2018.12.006_bib5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1093\/cid\/ciu773","article-title":"Cerebrospinal fluid inhibitory quotients of antiretroviral drugs in HIV-infected patients are associated with compartmental viral control","volume":"60","author":"Calcagno","year":"2015","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejphar.2018.12.006_bib6","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12882-015-0192-4","article-title":"Tenofovir is associated with increased tubular proteinuria and asymptomatic renal tubular dysfunction in Ghana","volume":"16","author":"Chadwick","year":"2015","journal-title":"BMC Nephrol."},{"key":"10.1016\/j.ejphar.2018.12.006_bib7","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s11904-014-0221-0","article-title":"HIV associated neurocognitive disorders in the modern antiviral treatment era: prevalence, characteristics, biomarkers, and effects of treatment","volume":"11","author":"Chan","year":"2014","journal-title":"Curr. HIV\/AIDS Rep."},{"key":"10.1016\/j.ejphar.2018.12.006_bib8","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1007\/s13346-016-0293-z","article-title":"Nano-art and NeuroAIDS","volume":"6","author":"Das","year":"2016","journal-title":"Drug Deliv. Transl. Res."},{"key":"10.1016\/j.ejphar.2018.12.006_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11481-016-9692-7","article-title":"Biodegradable nanoparticles for delivery of therapeutics in CNS infection","volume":"12","author":"DeMarino","year":"2017","journal-title":"J. NeuroImmune Pharmacol.: Off. J. Soc. NeuroImmune Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.006_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.3389\/fnins.2015.00093","article-title":"Neurotoxic effects of AZT on developing and adult neurogenesis","volume":"9","author":"Demir","year":"2015","journal-title":"Front. Neurosci."},{"key":"10.1016\/j.ejphar.2018.12.006_bib11","article-title":"Amelioration of aluminum Maltolate-induced inflammation and endoplasmic reticulum stress-mediated apoptosis by tannoid principles of emblica officinalis in neuronal cellular model","author":"Dhivya Bharathi","year":"2018","journal-title":"Neurotox. Res."},{"key":"10.1016\/j.ejphar.2018.12.006_bib12","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1111\/joim.12570","article-title":"Alarmins and central nervous system inflammation in HIV-associated neurological disorders","volume":"281","author":"Gougeon","year":"2017","journal-title":"J. Intern. Med."},{"key":"10.1016\/j.ejphar.2018.12.006_bib13","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1073\/pnas.73.7.2424","article-title":"Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor","volume":"73","author":"Greene","year":"1976","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2018.12.006_bib14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.tiv.2005.11.007","article-title":"Cell culture models for the investigation of NRTI-induced mitochondrial toxicity.: relevance for the prediction of clinical toxicity","volume":"20","author":"H\u00f6schele","year":"2006","journal-title":"Toxicol. Vitr."},{"key":"10.1016\/j.ejphar.2018.12.006_bib15","first-page":"39","article-title":"Novel mechanisms of central nervous system damage in HIV infection","volume":"2","author":"Hazleton","year":"2010","journal-title":"HIV\/AIDS - Res. Palliat. Care."},{"key":"10.1016\/j.ejphar.2018.12.006_bib16","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nrd1201","article-title":"Mitochondrial toxicity of NRTI antiviral drugs: an integrated cellular perspective","volume":"2","author":"Lewis","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejphar.2018.12.006_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.spen.2012.02.007","article-title":"Human immunodeficiency virus and the central nervous system","volume":"19","author":"Mirza","year":"2012","journal-title":"Semin. Pediatr. Neurol."},{"key":"10.1016\/j.ejphar.2018.12.006_bib18","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.addr.2016.02.008","article-title":"Getting into the brain: potential of nanotechnology in the management of NeuroAIDS","volume":"103","author":"Nair","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejphar.2018.12.006_bib19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1007\/s13365-012-0120-3","article-title":"Antiretroviral neurotoxicity","volume":"18","author":"Robertson","year":"2012","journal-title":"J. Neurovirology."},{"key":"10.1016\/j.ejphar.2018.12.006_bib20","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/QAD.0000000000001466","article-title":"Tenofovir disoproxil fumarate-associated renal tubular dysfunction: noninvasive assessment of mitochondrial injury","volume":"31","author":"Samuels","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/j.ejphar.2018.12.006_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.mcn.2012.12.005","article-title":"Human immunodeficiency virus-1 protein Tat induces excitotoxic loss of presynaptic terminals in hippocampal cultures","volume":"54","author":"Shin","year":"2013","journal-title":"Mol. Cell. Neurosci."},{"key":"10.1016\/j.ejphar.2018.12.006_bib22","doi-asserted-by":"crossref","first-page":"e0187424","DOI":"10.1371\/journal.pone.0187424","article-title":"Beyond the polymerase-\u03b3 theory: production of ROS as a mode of NRTI-induced mitochondrial toxicity","volume":"12","author":"Smith","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.ejphar.2018.12.006_bib23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1093\/arclin\/acx083","article-title":"Semantic memory in HIV-associated neurocognitive disorders: an evaluation of the \"cortical\" versus \"subcortical\" hypothesis","volume":"33","author":"Tierney","year":"2017","journal-title":"Arch. Clin. Neuropsychol."},{"key":"10.1016\/j.ejphar.2018.12.006_bib24","doi-asserted-by":"crossref","first-page":"61","DOI":"10.6000\/1927-3037.2015.04.02.3","article-title":"Current situation of PC12 cell use in neuronal injury study","volume":"4","author":"Wang","year":"2015","journal-title":"Int. J. Biotechnol. Wellness Ind."},{"key":"10.1016\/j.ejphar.2018.12.006_bib25","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.addr.2009.11.020","article-title":"Nanotechnology applications for improved delivery of antiretroviral drugs to the brain","volume":"62","author":"Wong","year":"2010","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ejphar.2018.12.006_bib26","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1007\/s11481-017-9755-4","article-title":"Combined medication of antiretroviral drugs tenofovir disoproxil fumarate, emtricitabine, and raltegravir reduces neural progenitor cell proliferation in vivo and in vitro","volume":"12","author":"Xu","year":"2017","journal-title":"J. NeuroImmune Pharmacol.: Off. J. Soc. NeuroImmune Pharmacol."},{"key":"10.1016\/j.ejphar.2018.12.006_bib27","doi-asserted-by":"crossref","first-page":"39922","DOI":"10.18632\/oncotarget.16485","article-title":"HIV-1 Tat inhibits EAAT-2 through AEG-1 upregulation in models","volume":"8","author":"Ye","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.ejphar.2018.12.006_bib28","doi-asserted-by":"crossref","first-page":"46344","DOI":"10.1038\/srep46344","article-title":"Tenofovir and adefovir down-regulate mitochondrial chaperone TRAP1 and succinate dehydrogenase subunit B to metabolically reprogram glucose metabolism and induce nephrotoxicity","volume":"7","author":"Zhao","year":"2017","journal-title":"Sci. Rep."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918307039?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299918307039?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,11,17]],"date-time":"2020-11-17T00:27:03Z","timestamp":1605572823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299918307039"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":28,"alternative-id":["S0014299918307039"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.12.006","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tenofovir disoproxil fumarate induces pheochromocytoma cells apoptosis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2018.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}